NINDS Efficacy Clinical Trials (U01) - Clinical Trial Required
Funding Opportunity PAR-18-422 from the NIH Guide for Grants and Contracts. The purpose of this Funding Opportunity Announcement (FOA) is to encourage grant applications for investigator-initiated efficacy clinical trials to the National Institute of Neurological Disorders and Stroke (NINDS). The trials must address questions within the mission and research interests of the NINDS and may evaluate drugs, biologics, and devices, as well as surgical, behavioral and rehabilitation therapies. Information about the mission and research interests of the NINDS can be found at the NINDS website (http://www.ninds.nih.gov/) (Sourc...
Source: NIH Funding Opportunities (Notices, PA, RFA) - November 29, 2017 Category: Research Source Type: funding
NIDDK Exploratory Clinical Trials for Small Business (R44 Clinical Trial Required)
Funding Opportunity PAR-18-108 from the NIH Guide for Grants and Contracts. The purpose of this Funding Opportunity Announcement (FOA) is to provide a vehicle for Small Business Concerns (SBCs) submitting Small Business Innovation Research (SBIR) grant applications for investigator-initiated exploratory clinical trials to the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK). The projects must focus on products related to the mission and goals of the NIDDK and may evaluate drugs, biologics, or devices, as well as surgical, behavioral or rehabilitation therapies. The purpose of this Funding Opportu...
Source: NIH Funding Opportunities (Notices, PA, RFA) - November 28, 2017 Category: Research Source Type: funding
NIDDK Exploratory Clinical Trials for Small Business (R44 Clinical Trial Required)
The purpose of this Funding Opportunity Announcement (FOA) is to provide a vehicle for Small Business Concerns (SBCs) submitting Small Business Innovation Research (SBIR) grant applications for investigator-initiated exploratory clinical trials to the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK). The projects must focus on products related to the mission and goals of the NIDDK and may evaluate drugs, biologics, or devices, as well as surgical, behavioral or rehabilitation therapies. The purpose of this Funding Opportunity Announcement (FOA) is to provide a vehicle for Small Business Concerns (SB...
Source: NIDDK Funding Opportunities - November 28, 2017 Category: Endocrinology Source Type: funding
Reducing the Duration of Untreated Psychosis in the United States (R01 Clinical Trial Required)
Funding Opportunity PAR-18-233 from the NIH Guide for Grants and Contracts. Approximately 100,000 adolescents and young adults in the United States experience a first episode of psychosis (FEP) every year. The early phase of psychotic illness is widely viewed as a critical opportunity for indicated prevention, and a chance to alter the downward trajectory and poor outcomes associated with schizophrenia and related psychotic disorders. Compared to traditional treatment approaches, programs that integrate pharmacologic, psychological, and rehabilitation interventions for FEP, i.e., team-based Coordinated Specialty Care (C...
Source: NIH Funding Opportunities (Notices, PA, RFA) - November 21, 2017 Category: Research Source Type: funding
Reducing the Duration of Untreated Psychosis in the United States (R34 Clinical Trial Required)
Funding Opportunity PAR-18-232 from the NIH Guide for Grants and Contracts. Approximately 100,000 adolescents and young adults in the United States experience a first episode of psychosis (FEP) every year. The early phase of psychotic illness is widely viewed as a critical opportunity for indicated prevention, and a chance to alter the downward trajectory and poor outcomes associated with schizophrenia and related psychotic disorders. Compared to traditional treatment approaches, programs that integrate pharmacologic, psychological, and rehabilitation interventions for FEP, i.e., team-based Coordinated Specialty Care (C...
Source: NIH Funding Opportunities (Notices, PA, RFA) - November 21, 2017 Category: Research Source Type: funding
Human-Animal Interaction (HAI) Research (R01 Clinical Trial Optional)
Funding Opportunity PAR-18-213 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) invites grant applications for research to examine 1) the impact of HAI on typical and atypical child development and health; 2) the evaluation of animal-assisted intervention for children and adults with disabilities or in need of rehabilitative services; 3) the effects of animals on public health, including cost effectiveness of involving animals in reducing and preventing disease. (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - November 21, 2017 Category: Research Source Type: funding
Research To Address Sleep Disorders in the Context of Medical Rehabilitation (R01 Clinical Trial Optional)
Funding Opportunity PAR-18-212 from the NIH Guide for Grants and Contracts. Patients with many disabilities report problems sleeping, but specific sleep disorders are often not diagnosed. Because sleep affects many physiological and behavioral parameters--depression, anxiety, pain, cancer, cardiovascular changes, immune function-- sleep disorders should be diagnosed and appropriately treated to maximize benefit of rehabilitation. Research is needed on ways to best approach this complexity in the context of medical rehabilitation for a primary, non-sleep disorder. (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - November 21, 2017 Category: Research Source Type: funding
NCMRR Early Career Research Award (R03 Clinical Trial Optional)
Funding Opportunity PAR-18-211 from the NIH Guide for Grants and Contracts. The National Center for Medical Rehabilitation Research (NCMRR) Early Career Research (ECR) Award (R03) is intended to support both basic and clinical research from rehabilitation scientists who are establishing independent research careers. It cannot be used to support thesis/dissertation research or research conducted by postdoctoral fellows. The research should be focused on one or more of the areas within the biomedical and behavioral mission of NCMRR: pathophysiology and management of chronically injured nervous and musculoskeletal systems;...
Source: NIH Funding Opportunities (Notices, PA, RFA) - November 21, 2017 Category: Research Source Type: funding
Behavioral Interventions for Prevention of Opioid Use Disorder or Adjunct to Medication Assisted Treatment-SAMHSA Opioid STR Grants (R21/R33)
Funding Opportunity RFA-AT-18-002 from the NIH Guide for Grants and Contracts. The purpose of this FOA is to solicit applications to examine the impact of behavioral interventions within the context of states plans for use of the SAMHSA Opioid STR grant funds authorized under the 21st Century Cures Act. Applications are encouraged for studies that examine the impact of interventions such as mindfulness meditation, cognitive behavioral therapy, or multi-disciplinary rehabilitation for primary or secondary prevention for opioid use disorder (OUD) or as an adjunct to medication assisted treatment (MAT) of OUD. Applications...
Source: NIH Funding Opportunities (Notices, PA, RFA) - November 16, 2017 Category: Research Source Type: funding
Clinical Trials to Test the Effectiveness of Treatment, Preventive, and Services Interventions (R01- Clinical Trial Required)
Funding Opportunity RFA-MH-18-701 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) seeks to support clinical trials to establish the effectiveness of interventions and to test hypotheses regarding moderators, mediators, and mechanisms of action of these interventions. This FOA supports clinical trials designed to test the therapeutic value of treatment and preventive interventions for which there is already evidence of efficacy, for use in community and practice settings. Applications might include research to evaluate the effectiveness or increase the clinical impact of pharmacol...
Source: NIH Funding Opportunities (Notices, PA, RFA) - November 14, 2017 Category: Research Source Type: funding
Clinical Trials to Test the Effectiveness of Treatment, Preventive, and Services Interventions (Collaborative R01-Clinical Trial Required)
Funding Opportunity RFA-MH-18-700 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) seeks to support clinical trials to establish the effectiveness of interventions and to test hypotheses regarding moderators, mediators, and mechanisms of action of these interventions. This FOA supports clinical trials designed to test the therapeutic value of treatment and preventive interventions for which there is already evidence of efficacy, for use in community and practice settings. Applications might include research to evaluate the effectiveness or increase the clinical impact of pharmacol...
Source: NIH Funding Opportunities (Notices, PA, RFA) - November 14, 2017 Category: Research Source Type: funding
Cellular and Biochemical Engineering (CBE)
Full Proposal Window: October 20, 2017 Program Guidelines: PD 17-1491The Cellular and Biochemical Engineering program is part of the Engineering Biology and Health cluster, which includes also 1) Engineering of Biomedical Systems; 2) Biophotonics; 3) Nano-Biosensing; and 4) Disability and Rehabilitation Engineering.
The Cellular and Biochemical Engineering (CBE) program supports fundamental engineering research that advances the understanding of cellular and biomolecular processes in engineering biology ...More at https://www.nsf.gov/funding/pgm_summ.jsp?pims_id=505334&WT.mc_id=USNSF_39&WT.mc_ev=clickThis i...
Source: NSF Upcoming Due Dates - September 20, 2017 Category: Science Source Type: funding
Disability and Rehabilitation Engineering (DARE)
Full Proposal Window: October 20, 2017 Program Guidelines: PD 17-5342The Disability and Rehabilitation Engineering program is part of the Engineering Biology and Health cluster, which includes also 1) Cellular and Biochemical Engineering; 2) Engineering of Biomedical Systems; 3) Biophotonics; and 4) Nano-Biosensing.
The Disability and Rehabilitation Engineering program supports fundamental engineering research that will improve the quality of life of persons with disabilities through: development of new ...More at https://www.nsf.gov/funding/pgm_summ.jsp?pims_id=505335&WT.mc_id=USNSF_39&WT.mc_ev=clickThis is an ...
Source: NSF Upcoming Due Dates - September 20, 2017 Category: Science Source Type: funding
Engineering of Biomedical Systems (EBMS)
Full Proposal Window: October 20, 2017 Program Guidelines: PD 17-5345The Engineering of Biomedical Systems program is part of the Engineering Biology and Health cluster, which includes also 1) Cellular and Biochemical Engineering; 2) Biophotonics; 3) Nano-Biosensing; and 4) Disability and Rehabilitation Engineering.
The goal of the Engineering of Biomedical Systems (EBMS) program is to provide research opportunities to develop novel ideas into discovery-level and transformative projects that integrate ...More at https://www.nsf.gov/funding/pgm_summ.jsp?pims_id=501023&WT.mc_id=USNSF_39&WT.mc_ev=clickThis is an NS...
Source: NSF Upcoming Due Dates - September 20, 2017 Category: Science Source Type: funding
Nano-Biosensing
Full Proposal Window: October 20, 2017 Program Guidelines: PD 17-7909The Nano-Biosensing program is part of the Engineering Biology and Health cluster, which includes also 1) Cellular and Biochemical Engineering; 2) Engineering of Biomedical Systems; 3) Biophotonics; and 4) Disability and Rehabilitation Engineering.
The Nano-Biosensing program supports fundamental engineering research on devices and methods for measurement and quantification of biological analytes. Proposals that incorporate emerging nanotechnology ...More at https://www.nsf.gov/funding/pgm_summ.jsp?pims_id=505340&WT.mc_id=USNSF_39&WT.mc_ev=clickThis is a...
Source: NSF Upcoming Due Dates - September 20, 2017 Category: Science Source Type: funding
